Reimbursement Past Sema denied as not medically necessary by Aetna?

Aetna's specific coverage criteria for reimbursement past sema are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denies Past Semaglutide Claims as Not Medically Necessary

For retrospective reimbursement claims, Aetna's medical-necessity review asks whether the clinical documentation present at the time of service would have satisfied Aetna's prior authorization criteria had they been submitted prospectively. Denials in this category most commonly occur because: (1) the prescriber's chart did not document the qualifying diagnosis with sufficient specificity; (2) required prior-treatment history (for weight management indications, prior behavioral/lifestyle intervention; for diabetes indications, prior oral agent trials) was not recorded in the submitted records; or (3) clinical severity indicators were not documented in the chart in a way that maps to Aetna's coverage criteria. The fact that the drug was prescribed and dispensed does not, by itself, satisfy Aetna's retrospective medical-necessity standard.

## Why This Denial Is Appealable

Retrospective medical-necessity determinations are fully appealable. Federal regulations require Aetna to apply the same clinical criteria on retrospective review that it would have applied prospectively — it cannot impose new or higher standards after the fact. If the prescriber's chart does contain the required clinical information but it was not included in the initial claim submission, supplementing the record on appeal is expressly permitted.

## Federal Appeal Framework

• Internal appeal: File within 180 days of the denial notice. Submit the complete clinical record — not just the claim form — with a cover letter that maps each of Aetna's stated medical-necessity criteria to a specific chart entry.
• External review (ACA §2719): Available after internal exhaustion, within approximately four months of final denial. Binding on Aetna. Particularly valuable when Aetna's internal review ignored chart evidence that was submitted.
• ERISA §503: Full-and-fair review rights apply to self-funded employer plans.

## Documentation to Gather

1. Complete prescriber chart notes — office visit notes from the period of service, including the documented diagnosis, severity assessment, and clinical rationale for semaglutide. 2. Prior treatment history with dates and outcomes — records of any prior interventions (lifestyle programs, behavioral health support, prior medications) with dates, duration, and documented outcomes. 3. Relevant lab or diagnostic results — confirming the qualifying diagnosis at the time of service. Do not include specific numeric values in your appeal cover letter; instead reference the chart and let the reviewer apply Aetna's thresholds. 4. Prescriber's medical-necessity letter — a signed letter written after the denial that explicitly addresses each criterion in Aetna's current clinical policy for semaglutide, cross-referencing chart entries. 5. Aetna's clinical policy document — request the version in effect at the time of service so your appeal addresses the correct criteria.

## Criteria-Mapping Structure

Obtain Aetna's clinical policy for the relevant indication. Build a table: each criterion in the left column, the specific chart entry (with date and document type) that satisfies it in the right column. Attach the full referenced chart entries as numbered exhibits. This format eliminates ambiguity about whether the documentation exists.